Back to Search
ANDREA DELACRUZ, D.O.
D.O.
Pediatrics Physician
NPI: 1982915682Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
0102202885(VA)OS16937(FL)
Research & Publications (8)
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
PMID 19375217·Eur Urol·2009
3-trial
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer.
PMID 18362364·J Clin Oncol·2008
3-trial
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.
PMID 17363532·Clin Cancer Res·2007
3-trial
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
PMID 16243819·Clin Cancer Res·2005
3-trial
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
PMID 15735119·J Clin Oncol·2005
3-trial
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
PMID 15112267·Cancer·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4951 GRANDE DR
PENSACOLA, FL 32504 - Phone
- (850) 473-0100
Quick Facts
- NPI
- 1982915682
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile